海外の治験の状況「COVID-19」での検索結果
94件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- Comparison between sedation with subcutaneuos ketamine and sedation with propofol in patients undergoing colonoscopy procedures
- Mental and behavioural disorders due to use of sedatives or hypnotics. Mental and behavioural disorders due to use of sedatives or hypnotics;F10-19;Mental and behavioural disorders due to use of sedatives or hypnotics
- Iran (Islamic Republic of)
- 2012-09-29
Not Recruiting
- Subcutaneous Dissociative Conscious Sedation (CDS) an Alternative Method for General Anesthesia in Rigid Bronchoscopy
- Mental and behavioural disorders due to use of sedatives or hypnotics. Mental and behavioural disorders due to use of sedatives or hypnotics;F10-19;Mental and behavioural disorders due to use of sedatives or hypnotics
- Iran (Islamic Republic of)
- 2012-11-25
Not Recruiting
- A comparison between general anesthesia versus dissociative conscious sedation in hemodynamic responses to endobronchial intubation.
- Mental and behavioural disorders due to use of sedatives or hypnotics. Mental and behavioural disorders due to use of sedatives or hypnotics;F10-19;Mental and behavioural disorders due to use of sedatives or hypnotics
- Iran (Islamic Republic of)
- 2012-11-25
Not Recruiting
- A comparison between general anesthesia versus dissociative conscious sedation in hemodynamic responses to tracheal intubation.
- Mental and behavioural disorders due to use of sedatives or hypnotics. Mental and behavioural disorders due to use of sedatives or hypnotics;F10-19;Mental and behavioural disorders due to use of sedatives or hypnotics
- Iran (Islamic Republic of)
- 2012-11-25
Recruiting
- Coping skills in adolescent with Acute Leukamia
- Adolescent in the age of 14 to 19 diagnosed with Acute Lymphoblastic leukemia with a curative intent
- India
- 2018-01-18
Not Recruiting
- effect of intravenous acetaminophen on pain manegement
- Condition 1: burn. Condition 2: burn. Condition 3: burn. Condition 4: burn. Condition 5: burn. Condition 6: burn. Condition 7: burn. Burn of second degree, body region unspecified Burn of third degree, body region unspecified Burns involving 10-19% of body surface Burns involving 20-29% of body surface Burns involving 30-39% of body surface Burns involving 40-49% of body surface Burns involving 50-59% of body surface;Burn of second degree, body region unspecified;Burn of third degree, body region unspecified;Burns involving 10-19% of body surface;Burns involving 20-29% of body surface;Burns involving 30-39% of body surface;Burns involving 40-49% of body surface;Burns involving 50-59% of body surface
- Iran (Islamic Republic of)
- 2011-06-30
Recruiting
- New Treatment for Radical Cure of Dengue Fever with Antiviral and Anti-cytokine
- Dengue Fever Patient-3 days fever-severe body&joints pain-conjuntival congestion-retro bulbar tenderness-Rashes-headache-nausea; male,female all age. Dengue detection Elisa NS1 IgM & IgG & DENV-RTPCR
- India
- 2017-12-11
Not Recruiting
- Evaluation of immunogenicity of Single dose Live Attenuated Varicella Vaccine
- Healthy children of either sex who received test varicella vaccination (VR 795 varicella Oka strain) as part of the Phase III clinical trial (WOC/VAC/VAR/CT â?? 19 â??PRT)
- India
- 2015-02-10
Authorised
- Afatinib as second-line therapy for lung cancer with EGFR mutation
- Metastatic non-small cell lung cancer harbouring an EGFR mutation (Del 19 or L858R) MedDRA version: 17.0 Level: PT Classification code 10029522 Term: Non-small cell lung cancer stage IV System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 17.0 Level: PT Classification code 10029521 Term: Non-small cell lung cancer stage IIIB System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 17.0 Level: PT Classification code 10059515 Term: Non-small cell lung cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 17.0 Level: PT Classification code 10061873 Term: Non-small cell lung cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Algeria, Egypt, Malaysia, Philippines, Poland, Romania, Serbia, Thailand, Tunisia
- 2014-07-02
Authorised
- A global study to assess the effects of osimertinib following chemoradiation in patients with Stage III unresectable non-small cell lung cancer (LAURA).
- Histologically documented non-small cell lung cancer of predominantly non-squamous pathology who present with locally advanced, unresectable (Stage III) disease, whose tumor tissue has EGFR exon 19 deletions or exon 21 (L858R) substitution mutations, either alone or in combination with other EGFR mutations, as detected by cobas® EGFR Mutation Test v2 (Roche Diagnostics) and whose disease has not progressed following definitive platinum-based chemoradiation. MedDRA version: 20.0 Level: PT Classification code 10029519 Term: Non-small cell lung cancer stage III System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, China, India, Japan, Korea, Republic of, Spain, Taiwan, Thailand, Turkey, United States, Vietnam
- 2018-06-21
